Generated by AI
Summary of Nov 18's posts. Generated by AI.
Summary of Nov 2's posts. Generated by AI.
Summary of May 7's posts. Generated by AI.
Summary of Sep 1's posts. Generated by AI.
Investors talking about OSRH also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.
OSR Health, Inc. is a healthcare holding company focused on developing and supporting a portfolio of biomedical therapies and medical technologies. Through its subsidiaries, the company is active in oral immunotherapies for cancer, design-augmented biologics for degenerative and age-related conditions, neurovascular intervention devices and systems, and non-invasive blood glucose monitoring technologies. It also distributes medical devices and related systems in Korea, giving it a mix of therapeutic development and commercial healthcare operations. Headquartered in Bellevue, Washington, OSR Health operates across the United States, Europe, and Korea, using a hub-and-spoke structure to manage specialized businesses in biotechnology, medtech, and healthcare distribution. The company’s role in the market is centered on advancing clinical-stage and preclinical assets while maintaining a diversified healthcare platform across multiple product categories.
Website10900 NE 4th Street
Bellevue, WA, 98004
United States
The latest articles about OSRH.
Tipranks Press Release.
NEW YORK CITY, NY / ACCESS Newswire / August 27, 2026 / Emerging Growth Research, LLC ("Emerging Growth Research" or "EGR") today announced the release of its company-sponsored research flash report on (NASDAQ:OSRH), a global healthcare holding company advancing oral immunotherapies for cancer and age-related disease, non-invasive glucose monitoring technology, and fourth-party logistics (4PL) operations.This release is being issued as an updated version of EGR's previously published press relea
Detailed price information for Osr Health Inc (OSRH) from The Globe and Mail including charting and trades.
The Company details its Nasdaq hearing request, its $15 million Put Option, and continued development across its subsidiary pipeline BELLEVUE, WA / ACCESS Newswire / August 21, 2026 / OSR Health, Inc. (NASDAQ:OSRH) today released the following ...